Oncolytics Biotech Inc. | Key People and Executives
Matthew C. Coffey
President, CEO, COO & Director
Deborah M. Brown
Independent Director
Bernd Robert Seizinger
Independent Director
William G. Rice
Independent Director
Angela Holtham
Independent Director
J. Mark Lievonen
Independent Director
Matthew C. Coffey
President, CEO, COO & Director
Kirk J. Look
Chief Financial Officer
Andrew R. de Guttadauro
Global Head-Business Development
Alan J. Tuchman
Chief Neuro Oncology Research Officer
Michael Moore
Vice President-Investor Relations & Communications
George M. Gill
Chief Safety Officer & SVP-Regulatory Affairs
Deborah M. Brown
Independent Director
Bernd Robert Seizinger
Independent Director
William G. Rice
Independent Director
Angela Holtham
Independent Director
J. Mark Lievonen
Independent Director
| Address |
1167 Kensington Crescent NW
Calgary Alberta T2N 1X7
Canada
|
|
Employees
|
- |
| Website |
http://www.oncolyticsbiotech.com |
| Updated |
07/08/2019 |
| Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus called REOLYSIN. The company was founded by Matthew C. |
